BACKGROUND: Empirical evidence on the epidemiology of hypertension, diabetes and hypercholesterolemia is limited in many countries in Central and Eastern Europe. We aimed to estimate the prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia in the Czech Republic, Russia, Poland and Lithuania, and to identify the risk factors for the three chronic conditions. METHODS: We analysed cross-sectional data from the HAPIEE study, including adults aged 45-69 years in the Czech Republic, Russia, Poland and Lithuania, collected between 2002 and 2008 (total sample N = 30,882). Among prevalent cases, we estimated awareness, treatment, and control of hypertension, diabetes and hypercholesterolemia by gender and country. Multivariate logistic regression was applied to identify associated risk factors. RESULTS: In each country among both men and women, we found high prevalence but low control of hypertension, diabetes, and hypercholesterolemia. Awareness rates of hypertension were the lowest in both men (61.40%) and women (69.21%) in the Czech Republic, while awareness rates of hypercholesterolemia were the highest in both men (46.51%) and women (51.20%) in Poland. Polish participants also had the highest rates of awareness (77.37% in men and 79.53% in women), treatment (71.99% in men and 74.87% in women) and control (30.98% in men and 38.08% in women) of diabetes. The common risk factors for the three chronic conditions were age, gender, education, obesity and alcohol consumption. CONCLUSIONS: Patterns of awareness, treatment and control rates of hypertension, diabetes and hypercholesterolemia differed by country. Efforts should be made in all four countries to control these conditions, including implementation of international guidelines in everyday practice to improve detection and effective management of these conditions.

Department of Epidemiology and Population Studies Institute of Public Health Faculty of Health Sciences Jagiellonian University Medical College Kraków Poland

Institute of Cardiology Lithuanian University of Health Sciences Kaunas Lithuania

National Institute of Public Health Prague Czech Republic

RECETOX Masaryk University Brno Czech Republic

Research Department of Epidemiology and Public Health University College London London UK

Research Institute of Internal and Preventive Medicine Branch of Federal Research Center Institute of Cytology and Genetics Siberian Branch of RAS Novosibirsk Russia

See more in PubMed

Movsisyan NK, Vinciguerra M, Medina-Inojosa JR, Lopez-Jimenez F. Cardiovascular diseases in central and eastern Europe: a call for more surveillance and evidence-based health promotion. Ann Glob Health. 2020;86(1):21. doi: 10.5334/aogh.2713. PubMed DOI PMC

Niklas A, Flotyńska A, Puch-Walczak A, Polakowska M, Topór-Mądry R, Polak M, et al. Prevalence, awareness, treatment and control of hypertension in the adult Polish population - Multi-center National Population Health Examination Surveys - WOBASZ studies. Arch Med Sci. 2018;14(5):951–961. doi: 10.5114/aoms.2017.72423. PubMed DOI PMC

Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, et al. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health. 2016;15(1):199. doi: 10.1186/s12939-016-0478-6. PubMed DOI PMC

Rotar O, Konradi A, Tanicheva A, Nakonechnikov S, Blinova N, Beaney T, et al. May Measurement Month 2017 in Russia: hypertension treatment and control-Europe. Eur Heart J Suppl. 2019;21(Suppl D):D101–D103. doi: 10.1093/eurheartj/suz068. PubMed DOI PMC

Cybulsky M, Cook S, Kontsevaya AV, Vasiljev M, Leon DA. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk. Russia BMC Cardiovasc Disord. 2016;16:122. doi: 10.1186/s12872-016-0300-9. PubMed DOI PMC

Artyukhov IP, Grinshtein YI, Petrova MM, Shabalin VV, Ruf RR. Prevalence of arterial hypertension in the Krasnoyarsk Krai (Siberia, Russia) BMC Cardiovasc Disord. 2017;17(1):138. doi: 10.1186/s12872-017-0559-5. PubMed DOI PMC

Rywik SL, Davis CE, Pajak A, Broda G, Folsom AR, Kawalec E, et al. Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA Project and the U.S. Atherosclerosis Risk in Communities Study. Ann Epidemiol. 1998;8(1):3–13. doi: 10.1016/S1047-2797(97)00177-4. PubMed DOI

Bikbov MM, Kazakbaeva GM, Zainullin RM, Salavatova VF, Gilmanshin TR, Yakupova DF, et al. Prevalence, awareness, and control of arterial hypertension in a Russian population. The Ural Eye and Medical Study. Front Public Health. 2019;7:394. doi: 10.3389/fpubh.2019.00394. PubMed DOI PMC

Szuba A, Martynowicz H, Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, et al. Prevalence of hypertension in a sample of Polish population - baseline assessment from the prospective cohort 'PONS' study. Ann Agric Environ Med. 2011;18(2):260–264. PubMed

Niklas AA, Flotyńska A, Zdrojewski T, Pająk A, Topór-Mądry R, Nadrowski P, et al. Trends in hypertension prevalence, awareness, treatment, and control among Polish adults 75 years and older during 2007–2014. Cardiol J. 2018;25(3):333–344. doi: 10.5603/CJ.a2018.0043. PubMed DOI

Zdrojewski T, Wizner B, Więcek A, Ślusarczyk P, Chudek J, Mossakowska M, et al. Prevalence, awareness, and control of hypertension in elderly and very elderly in Poland: results of a cross-sectional representative survey. J Hypertens. 2016;34(3):532–8. doi: 10.1097/HJH.0000000000000823. PubMed DOI

Cífková R, Skodová Z, Lánská V, Adámková V, Novozámská E, Jozífová M, et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001 Czech Post-MONICA Study. J Hum Hypertens. 2004;18(8):571–9. doi: 10.1038/sj.jhh.1001686. PubMed DOI

Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M, et al. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985–2016/17. PLoS One. 2020;15(5):e0232845. doi: 10.1371/journal.pone.0232845. PubMed DOI PMC

Cífková R, Skodová Z, Lánská V, Adámková V, Novozámská E, Petrzílková Z, et al. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. J Hypertens. 2004;22(8):1479–1485. doi: 10.1097/01.hjh.0000133737.77866.3e. PubMed DOI

Reklaitiene R, Tamosiunas A, Virviciute D, Baceviciene M, Luksiene D. Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983–2009. BMC Cardiovasc Disord. 2012;12:68. doi: 10.1186/1471-2261-12-68. PubMed DOI PMC

Bikbov MM, Fayzrakhmanov RR, Kazakbaeva GM, Zainullin RM, Arslangareeva II, Gilmanshin TR, et al. Prevalence, awareness and control of diabetes in Russia: the Ural Eye and Medical Study on adults aged 40+ years. PLoS ONE. 2019;14(4):e0215636. doi: 10.1371/journal.pone.0215636. PubMed DOI PMC

Zdrojewski T, Solnica B, Cybulska B, Bandosz P, Rutkowski M, Stokwiszewski J, et al. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol. 2016;74(3):213–23. doi: 10.5603/KP.2016.0029. PubMed DOI

Pająk A, Szafraniec K, Polak M, Polakowska M, Kozela M, Piotrowski W, et al. Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study. Pol Arch Med Wewn. 2016;126(9):642–652. PubMed

Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006;6:255. doi: 10.1186/1471-2458-6-255. PubMed DOI PMC

Bobak M, Marmot M. East-West mortality divide and its potential explanations: proposed research agenda. BMJ. 1996;312(7028):421–425. doi: 10.1136/bmj.312.7028.421. PubMed DOI PMC

Supiyev A, Kossumov A, Utepova L, Nurgozhin T, Zhumadilov Z, Bobak M. Prevalence, awareness, treatment and control of arterial hypertension in Astana Kazakhstan A cross-sectional study. Public Health. 2015;129(7):948–953. doi: 10.1016/j.puhe.2015.02.020. PubMed DOI

Supiyev A, Kossumov A, Kassenova A, Nurgozhin T, Zhumadilov Z, Peasey A, et al. Diabetes prevalence, awareness and treatment and their correlates in older persons in urban and rural population in the Astana region. Kazakhstan Diabetes Res Clin Pract. 2016;112:6–12. doi: 10.1016/j.diabres.2015.11.011. PubMed DOI

Supiyev A, Nurgozhin T, Zhumadilov Z, Peasey A, Hubacek JA, Bobak M. Prevalence, awareness, treatment and control of dyslipidemia in older persons in urban and rural population in the Astana region, Kazakhstan. BMC Public Health. 2017;17(1):651. doi: 10.1186/s12889-017-4629-5. PubMed DOI PMC

Tolonen H, Keil U, Ferrario M, Evans A, Project WM. Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol. 2005;34(1):181–92. doi: 10.1093/ije/dyi056. PubMed DOI

Zdrojewski T, Szpakowski P, Bandosz P, Pajak A, Wiecek A, Krupa-Wojciechowska B, et al. Arterial hypertension in Poland in 2002. J Hum Hypertens. 2004;18(8):557–562. doi: 10.1038/sj.jhh.1001739. PubMed DOI

Mohamed SF, Mwangi M, Mutua MK, Kibachio J, Hussein A, Ndegwa Z, et al. Prevalence and factors associated with pre-diabetes and diabetes mellitus in Kenya: results from a national survey. BMC Public Health. 2018;18(Suppl 3):1215. doi: 10.1186/s12889-018-6053-x. PubMed DOI PMC

Espirito Santo LR, Faria TO, Silva CSO, Xavier LA, Reis VC, Mota GA, et al. Socioeconomic status and education level are associated with dyslipidemia in adults not taking lipid-lowering medication: a population-based study. Int Health. 2019. Online first PubMed PMC

White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399. doi: 10.1002/sim.4067. PubMed DOI

StataCorp LLC. User’s guide. Texas: Stata Press; 2019.

N C D Risk Factor Collaboration Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. doi: 10.1016/S0140-6736(21)01330-1. PubMed DOI PMC

N C D Risk Factor Collaboration Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020;582(7810):73–7. doi: 10.1038/s41586-020-2338-1. PubMed DOI PMC

Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11–19. doi: 10.1097/00004872-200401000-00003. PubMed DOI

N C D Risk Factor Collaboration Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394(10199):639–51. doi: 10.1016/S0140-6736(19)31145-6. PubMed DOI PMC

Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30. doi: 10.1016/S0140-6736(16)00618-8. PubMed DOI PMC

Boo S, Yoon YJ, Oh H. Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: a cross-sectional analysis. Medicine (Baltimore) 2018;97(51):e13713. doi: 10.1097/MD.0000000000013713. PubMed DOI PMC

World Health Organization. Raised cholesterol 2012 [cited 2022. Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3236.

Gulayin PE, Irazola V, Gutierrez L, Elorriaga N, Lanas F, Mores N, et al. Association between drinking patterns and cardiovascular risk: a population-based study in the Southern Cone of Latin America. J Public Health (Oxf) 2020;42(1):107–117. doi: 10.1093/pubmed/fdy226. PubMed DOI PMC

Lancet T. Russia's alcohol policy: a continuing success story. Lancet. 2019;394(10205):1205. doi: 10.1016/S0140-6736(19)32265-2. PubMed DOI

Pajak A, Szafraniec K, Kubinova R, Malyutina S, Peasey A, Pikhart H, et al. Binge drinking and blood pressure: cross-sectional results of the HAPIEE study. PLoS One. 2013;8(6):e65856. doi: 10.1371/journal.pone.0065856. PubMed DOI PMC

Sedgwick P. What is recall bias? BMJ. 2012;344:e3519. doi: 10.1136/bmj.e3519. DOI

Sattar N, Preiss D. Reverse causality in cardiovascular epidemiological research: more common than imagined? Circulation. 2017;135(24):2369–2372. doi: 10.1161/CIRCULATIONAHA.117.028307. PubMed DOI

Cohen G, Duffy JC. Are nonrespondents to health surveys less healthy than respondents? J Off Stat. 2002;18(1):13–23.

Renders CM, Valk GD, Griffin SJ, Wagner EH, Van Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24(10):1821–1833. doi: 10.2337/diacare.24.10.1821. PubMed DOI

Tomasik T, Windak A, Jozwiak J, Oleszczyk M, Seifert B, Kersnik J, et al. Treatment of hypertension in central and eastern European countries: self-reported practice of primary care physicians. J Hypertens. 2012;30(8):1671–1678. doi: 10.1097/HJH.0b013e3283557f4e. PubMed DOI

Ionov MV, Zvartau NE, Konradi AO. Status of hypertension in Russia and Eastern Europe 2019 [Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-17/status-of-hypertension-in-russia-and-eastern-europe.

Cascade of care for hypertension among apparently healthy and unhealthy individuals of 25-64 years in the Czech Republic

The economic burden of obesity in 4 south-eastern European countries associated with obesity-related co-morbidities